Organ-Agents: Modular Multi-Organ Simulation

• Organ-Agents are computational frameworks that decompose complex multi-organ processes into specialized agents, enabling digital twin simulations and holistic treatment optimization.
• They employ inter-agent communication and reinforcement learning to dynamically integrate and correct predictions across individual organ systems.
• Evaluation shows high simulation fidelity with mean MSE below 0.16 and improved clinical decision support metrics, demonstrating significant potential for patient-specific modeling.

Organ-Agents are computational frameworks that decompose complex, multi-organ physiological or clinical reasoning processes into distributed, interacting agents—each modeling or controlling an individual organ system. This modular, agent-based approach leverages LLMs or reinforcement learning agents to simulate, coordinate, or optimize multi-system behaviors, with applications ranging from digital twin physiology to multi-organ treatment optimization (Chang et al., 20 Aug 2025, Tan et al., 2024).

1. Conceptual Foundations and Scope

Organ-Agents are designed to mirror the structural and functional modularity observed in biological organisms—especially in the context of human physiology, where multiple organ systems interact dynamically under both healthy and pathological conditions. The foundational goals are:

• Digital Twin Simulations: Patient-specific, high-resolution virtual replication of multi-organ trajectories.
• Holistic Clinical Decision Support: Learning and optimizing treatment strategies in multi-organ disease such as sepsis, where interventions for one organ may propagate effects to others.
• Mechanistic Interpretability: Enforcing modularity at the agent or system level to enable interpretation, counterfactual perturbation, and causal analysis.

Organ-Agents are instantiated as multi-agent systems where each agent specializes in modeling, simulating, or controlling the dynamics of an assigned organ or organ subsystem, communicating information and interventions via explicit inter-agent message passing or latent state exchange.

2. Architecture and Agent Roles

A canonical Organ-Agents system comprises the following architectural components, as formalized in recent work:

Agent Type	Role	Example (Chang et al., 20 Aug 2025)
Simulator	Predicts next-step time-series for a specific organ system	Cardiovascular, Renal, Immune
Correlator	Selects and injects cross-system variables for integration	Cross-organ reference selection
Compensator	Estimates and corrects low-confidence outputs	Residual error correction
Analyzer	Extracts and summarizes symbolic trends for interpretability	Symbolic within-agent summarizer

Each timestep, Simulator agents receive their own recent history, static baseline features, treatment history, and selected cross-system references. The Correlator, trained by reinforcement learning, optimizes the selection of external variables to minimize inter-agent prediction error while penalizing over-connectivity. The Compensator intervenes when agent self-confidence falls below a data-driven threshold, correcting predictions via residual modeling.

In reinforcement learning designs, such as the hierarchical multi-agent reinforcement learning (HMARL) framework (Tan et al., 2024), agent hierarchy reflects clinical decision decomposition from top-level coordinators (root agents) through organ-level controllers to fine-grained treatment dose agents. Explicit inter-agent communication augments policy coordination and supports holistic, patient-level optimization.

3. Training Paradigms and Optimization

Organ-Agents frameworks deploy hybrid or staged training protocols:

• Supervised Fine-Tuning (SFT): Each Simulator agent is initialized from a base LLM and fine-tuned on time-series data for its organ, targeting both token-level output reconstruction and numerical fidelity (mean squared error, confidence calibration).

$$\mathcal{L}_\mathrm{SFT} = \mathcal{L}_\mathrm{CE} + \mathcal{L}_\mathrm{cons} = \mathcal{L}_\mathrm{CE} + \mathrm{MSE}(\hat{y}_t, y_t) + \lambda\,\mathrm{MSE}(\hat{c}_t, \exp(-|\hat{y}_t - y_t|))$$

• Reinforcement-Guided Coordination: The Correlator is trained using Proximal Policy Optimization (PPO) to select cross-system references, with the reward defined as the reduction in Simulator MSE due to cross-organ input, minus a sparsity penalty.

$$r_t = \mathrm{MSE}(\hat{y}_t^{(0)}, y_t) - \mathrm{MSE}(\hat{y}_t, y_t)$$

The PPO objective incorporates entropy and $L_1$ regularization to enforce parsimony.

• Centralized Training, Decentralized Execution (CTDE): In RL-based architectures (Tan et al., 2024), agents are trained collectively to maximize a global reward (e.g., patient survival, lower SOFA score), but execute using only their local observations and policies at deployment.
• Residual Correction: The Compensator is separately trained to model the error distribution under conditions of low Simulator confidence.

This multi-stage approach ensures each agent is specialized yet capable of context-sensitive adaptation to global system states and policy changes.

4. Evaluation Methodologies and Results

Performance evaluation covers physiological fidelity, robustness, and decision-relevance:

• System-Level MSE: On held-out patient cohorts, Organ-Agents achieve mean per-system MSE below 0.16 across nine systems (Chang et al., 20 Aug 2025).
• Robustness Across Severity: Performance degrades modestly under high SOFA scores or external patient populations, with MSE increases <30% in the most dynamic systems.
• Physiological Event Replay: Canonical multi-system failure cascades (e.g., hypotension, hyperlactatemia, hypoxemia) are reproducibly simulated, with timing deviations ΔT under 2 hours and normalized error per event <0.25.
• Expert Validation: Critical care physicians rate simulated multi-system trajectories for realism (3.9/5 mean) and coherence (3.7/5 mean), with high correlation between Correlator reference selection and clinical plausibility.
• Counterfactual Simulations: Organ-Agents generate trajectory-level responses and risk score (APACHE II) shifts under alternate treatment policies (e.g., early vs. delayed resuscitation), aligning closely with matched real-world cohorts (score differences within ±1 point).
• Downstream Predictive Semantics: Early warning classifiers trained on Organ-Agents–synthesized data exhibit AUROC drops of ≤0.04 compared to real data, indicating preservation of decision-relevant patterns for clinical risk tasks.

The following table summarizes key simulation accuracy results (Chang et al., 20 Aug 2025):

System	Mean MSE ± SD	Pathway Accuracy (Event Cascade)
Respiratory	0.114 ± 0.020	0.84 (hypoxemia)
Cardiovascular	0.128 ± 0.025	0.86 (hypotension)
Metabolic	0.126 ± 0.019	0.79 (hyperlactatemia)

5. Communication Protocols and Inter-Agent Coordination

Explicit, structured communication is foundational for Organ-Agents frameworks:

• In Organ-Simulator paradigms (Chang et al., 20 Aug 2025), the Correlator agent dynamically selects which cross-system state variables are embedded into each Simulator’s prompt. This selection is guided by a PPO policy that balances mutual information with sparsity.
• Within HMARL architectures (Tan et al., 2024), inter-agent messaging follows a structured path: pure-treatment leaf agents propose dose recommendations, which are aggregated by mixture agents at each hierarchical tier; across-organ mixture agents concatenate and coordinate intervention proposals before delivering treatment commands.

Communication protocols enable the Organ-Agents network to integrate distributed information, resolve inter-system conflicts, and adapt to emergent global behaviors—key for complex scenarios like sepsis where cardiac, renal, and neurological interventions may interact.

6. Clinical Impact, Limitations, and Future Directions

Organ-Agents establish a scalable, generalizable model for high-fidelity, mechanistically interpretable simulation and optimization of multi-organ physiology:

• Clinical Decision Support: Hierarchical multi-agent policies reduce estimated sepsis mortality rates to 8.8% (±0.24), a significant improvement over existing clinician and single-agent baselines (best baseline: 11.3%) (Tan et al., 2024).
• Mechanistic Digital Twin: The modular agent structure mirrors biological reality and provides a testbed for hypothesis testing, counterfactual analysis, and treatment simulation (Chang et al., 20 Aug 2025).
• Expert-Rated Plausibility: Clinical realism validated by physicians supports the plausibility of downstream application for training, diagnosis, and real-time support.

Limitations include dependency on retrospective, de-identified datasets; lack of coverage for ultra-rare conditions or multimodal input domains (e.g., imaging, free-text); possible need for adjustment in real-time deployment contexts; and reliance on discrete action spaces that may not map directly to clinical dosing routines. Future work focuses on physician-in-the-loop reinforcement learning, model-based state transitions, and prospective validation in randomized clinical trials (Chang et al., 20 Aug 2025, Tan et al., 2024).

7. Comparative Context and Broader Implications

Organ-Agents frameworks mark a methodological advance over prior single-organ or black-box end-to-end models by enforcing modularity, transparency, and explicit inter-agent communication:

• Inter-Agent Coordination: RL-guided selection of information pathways enables dynamic adaptation to patient heterogeneity, physiological perturbations, and emergent multi-organ events.
• Generalization and Transferability: Preservation of semantic and statistical properties of real-world clinical data facilitates transfer of downstream models and fidelity under distribution shifts.
• Extensibility: Both Organ-Agents (Chang et al., 20 Aug 2025) and HMARL (Tan et al., 2024) frameworks are general, supporting plug-in of additional systems or domains, and suitable for both simulation and policy optimization tasks.

A plausible implication is that Organ-Agents architectures will serve as a backbone for future clinical AI systems, enabling transparent, holistic, and patient-adapted reasoning across the full spectrum of multi-organ pathophysiology and interventions.